Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ
Oncology
Dr. Edith P. Mitchell, MD
|
|
Give Review
Edith Mitchell is an expert in the field of Oncology. She studied medicine at Virginia Commonwealth University School of Medicine. She has 2 awards "Patient-Centered Specialty Practice Recognition Program" and "CMS Meaningful Use Stage 1 Certification". Doctor Edith P. Mitchell, MD is also published. She has 25 publications published. The lastest publication: "Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab With Panitumumab Versus Panitumumab Alone in Patients With Wild-Type KRAS Metastatic Colorectal Cancer.' Edith Mitchell accepts Medicare.
Publications
- Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab With Panitumumab Versus Panitumumab Alone in Patients With Wild-Type KRAS Metastatic Colorectal Cancer.
- Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study.
- Determining efficacy of breast Cancer therapy by PET imaging of HER2 mRNA.
- The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Ana...
- The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma.
- Management of hypersplenism by partial splenic embolization with ethylene vinyl alcohol copolymer.
- Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast Cancers.
- Long-term survival after colonic stenting and restenting for malignant colonic obstruction.
- Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on s...
- Higher incidence of aggressive breast Cancers in African-American women: a review.
- Clinical presentation and pathophysiology of EGFRI dermatologic toxicities.
- Clinical management of EGFRI dermatologic toxicities: US perspective.
- Scintigraphic imaging of body neuroendocrine tumors.
- Differences in Breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National...
- Bisphosphonate therapy for women with breast Cancer and at high risk for osteoporosis.
- Gastrointestinal toxicity of chemotherapeutic agents.
- Prognostic impact of race and ethnicity in the treatment of colorectal Cancer.
- Carcinoembryonic antigen in the staging and follow-up of patients with colorectal Cancer.
- Recommended guidelines for the treatment of Cancer treatment-induced diarrhea.
- Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal Cancer.
- Sudden-onset thrombocytopenia with oxaliplatin.
- Ocular surface, ocular adnexal, and lacrimal complications associated with the use of Systemic 5-fluorouracil.
- Prognosis after rectal Cancer treatment in blacks and whites: advanced stage at diagnosis or other factors?
- Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass.
Schools
Virginia Commonwealth University School Of Medicine
Meharry Medical College
Georgetown University Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Patient-Centered Specialty Practice Recognition Program
- CMS Meaningful Use Stage 1 Certification
Education
-
Virginia Commonwealth University School of Medicine
Hospital
-
Thomas Jefferson University Hospital
Drug Facts
| NPI NUMBER | 1639191984 | |
| NPPES Provider LastName | MITCHELL | |
| NPPES Provider FirstName | EDITH | |
| NPPES Provider ZIPCode | 191074824 | |
| NPPES Provider State | PA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 440.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639191984 |
| Last Name Of The Provider | MITCHELL |
| First Name Of The Provider | EDITH |
| View All |
Similar Doctors
|
Dr. Elizabeth R. Plimack, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ashwin R. Sama, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sameh R. Gaballa, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rita S. Axelrod, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Tara Gangadhar, MD
This Doctor is OpenDoctor Recommended.
|